null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

Chronic Myeloid Leukemia (A Handbook for Hematologists and Oncologists)

List Price: $87.99
SKU:
9781842145777
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    Tariq I. Mughal
    Format:
    Paperback
    Pages:
    152
    Publisher:
    CRC Press (April 25, 2013)
    Language:
    English
    Audience:
    Professional and scholarly
    ISBN-13:
    9781842145777
    Weight:
    10oz
    Dimensions:
    5.0625" x 7.8125"
    File:
    TAYLORFRANCIS-TayFran_260415045620654-20260415.xml
    Folder:
    TAYLORFRANCIS
    List Price:
    $87.99
    Case Pack:
    55
    As low as:
    $83.59
    Publisher Identifier:
    P-CRC
    Discount Code:
    H
    Pub Discount:
    30
    Country of Origin:
    United States
    Imprint:
    CRC Press
  • Overview

    Chronic myeloid leukemia is a clonal disease that results from an acquired genetic change in a single pluripotential hemopoietic stem cell. Efforts to confront this disease have been assisted by advances in cellular and molecular biology and the speed at which these findings have transformed the therapeutic algorithm. Nevertheless, there is some uncertainty in how best to assess efficacy of treatment, especially with regards to the most appropriate surrogate markers for overall survival. From the standpoint of biology and clinical management, this handbook provides an authoritative state-of-the-art review of current and developing progress.